GlassScriptPhysician profile
April J Corley
NPI 1871854943
$2,705.31
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.76 · 2020: $263 · 2021: $1,447 · 2022: $917.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,015.59 | 2020-2022 | |
| Amgen INC. | $247.54 | 2019-2022 | |
| Abbvie INC. | $217.19 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $182.36 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $111.51 | 2021 | |
| Abbott Laboratories | $95.61 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.17 | 2020-2022 | |
| Pfizer INC. | $91.19 | 2020-2022 | |
| Amarin Pharma, INC. | $87.38 | 2020-2021 | |
| Lilly USA, LLC | $70.86 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.91 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $61.68 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $43.94 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.90 | 2021 | |
| Cranial Technologies, INC | $35.99 | 2020-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $28.51 | 2022 | |
| Sunovion Pharmaceuticals INC. | $27.27 | 2019 | |
| Allergan, INC. | $25.01 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.94 | 2022 | |
| Esperion Therapeutics, INC. | $17.59 | 2021 | |
| Astellas Pharma US INC | $17.40 | 2021 | |
| Clarus Therapeutics INC. | $16.95 | 2021 | |
| Glaxosmithkline, LLC. | $16.89 | 2022 | |
| Sanofi Pasteur INC. | $15.80 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.84 | 2021 | |
| Hologic Sales and Service, LLC | $13.92 | 2021 | |
| Eisai INC. | $11.70 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.67 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Corley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.